Zomedica ZOMDF
OTC ZOMDF
$0.10 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Zomedica (ZOMDF) Preferred Stock Liabilities (2020 - 2021)

Updated

Zomedica's Preferred Stock Liabilities was $11.96 million in Q4 2021, unchanged from $11.96 million a year earlier.

Analysis

Zomedica (ZOMDF) Preferred Stock Liabilities (2020 - 2021) Analysis & Trends

  • In earlier years, Preferred Stock Liabilities was $11.96 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Zomedica 97.99 Mn -87.03 Mn 6.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 11.96 Mn
Mar 31, 2021 11.96 Mn
Dec 31, 2020 11.96 Mn
API Access

Zomedica Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY